Kingmed Diagnostics (603882.SH) released its first three quarters performance, with net profit attributable to the parent company of 374 million yuan, a year-on-year increase of 569.23%.

Zhitong Finance APP News, KingMed Diagnostics (603882.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 4.403 billion yuan, a year-on-year decrease of 2.99%; net profit attributable to the parent company was 374 million yuan, a year-on-year increase of 569.23%; net profit after deducting non-recurring gains and losses was 385 million yuan, a year-on-year increase of 556.43%; basic earnings per share were 0.81 yuan.